Northwest Biotherapeutics (NWBO) Selling, General & Administrative (2010 - 2026)
Northwest Biotherapeutics (NWBO) posted Selling, General & Administrative of $6.71 million for Q2 2026, down 10.3% from $7.48 million a year earlier but up 2.6% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Northwest Biotherapeutics was $28.94 million, down 9.7% year-over-year; for FY2025, it came in at $32.51 million, down 1.5% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- In prior years, Northwest Biotherapeutics' Selling, General & Administrative was $33 million in FY2024 (+11.1%), $29.71 million in FY2023 (-10.9%), $33.35 million in FY2022 (-0.1%) and $33.4 million in FY2021 (-38.4%).
- Quarterly Selling, General & Administrative has run from a low of $6.49 million in Q4 2021 to a high of $9.68 million in Q2 2024 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in four of the last eight quarters, with an average decline of 5.1%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2022, with growth of 45.2%; the weakest was Q3 2021, with a decline of 78.1%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $6.54 million (Q1 2026), $8.62 million (Q4 2025) and $7.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | 6.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.71 Mn |
| Mar 31, 2026 | 6.54 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 7.07 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 9.34 Mn |
| Dec 31, 2024 | 8.21 Mn |
| Sep 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | 8.09 Mn |
| Dec 31, 2023 | 8.13 Mn |
| Sep 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.56 Mn |
| Mar 31, 2023 | 6.98 Mn |
| Dec 31, 2022 | 9.42 Mn |
| Sep 30, 2022 | 8.13 Mn |
| Jun 30, 2022 | 7.93 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 6.49 Mn |
| Sep 30, 2021 | 6.65 Mn |
API Access
Northwest Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();